Allmed Medical Products002950.SZValuation Analysis

As of Oct 19, 2026, Allmed Medical Products (002950.SZ) trades at a P/E of 22.10x, P/B of 1.45x, P/S of 1.46x, and a dividend yield of 1.68%.
Longitudinal percentile comparison: P/E sits at the 54th percentile over the trailing 10Y window (vs. 48th percentile over 3Y); P/B sits at the 5th percentile over the trailing 10Y window (vs. 13th percentile over 3Y); P/S sits at the 4th percentile over the trailing 10Y window (vs. 11th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 25th percentile within its industry and the 29th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.63%, ranking at the 86th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 48.5 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 2.63% total shareholder yield, 1.68% is paid out as dividends and roughly 0.95% is implied to come from buybacks — both channels are meaningfully in play. Allmed Medical Products operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.